Vaneck Vectors Pharmaceutical etf shares owned by Citadel Advisors
Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Vaneck Vectors Pharmaceutical etf
Tip: Access up to 7 years of quarterly data
All positions including Vaneck Vectors Pharmaceutical etf held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $6.3M | 66k | 95.03 |
| 2024-06-30 | $229k | 2.5k | 91.48 |
| 2024-03-31 | $5.2M | 57k | 90.70 |
| 2023-12-31 | $5.1M | 63k | 81.37 |
| 2023-09-30 | $2.1M | 26k | 79.86 |
| 2023-06-30 | $3.2M | 41k | 78.77 |
| 2023-03-31 | $2.6M | 34k | 77.63 |
| 2022-12-31 | $2.6M | 33k | 77.74 |
| 2022-06-30 | $2.4M | 31k | 76.74 |
| 2022-03-31 | $1.3M | 16k | 79.79 |
| 2021-12-31 | $3.0M | 39k | 76.95 |
| 2021-09-30 | $4.2M | 58k | 72.71 |
| 2021-06-30 | $5.0M | 69k | 73.14 |
| 2021-03-31 | $5.1M | 74k | 69.01 |
| 2020-12-31 | $2.5M | 38k | 66.49 |
| 2020-09-30 | $4.3M | 69k | 62.17 |
| 2020-06-30 | $2.9M | 46k | 62.27 |
| 2020-03-31 | $2.7M | 49k | 54.40 |
| 2019-12-31 | $3.6M | 57k | 64.18 |
| 2019-09-30 | $2.8M | 49k | 56.89 |
| 2019-06-30 | $3.9M | 67k | 58.66 |
| 2019-03-31 | $2.1M | 34k | 60.71 |
| 2018-12-31 | $4.4M | 80k | 55.07 |
| 2018-09-30 | $1.5M | 24k | 64.33 |
| 2018-06-30 | $2.9M | 49k | 58.99 |
| 2018-03-31 | $1.1M | 20k | 56.73 |
| 2017-12-31 | $1.0M | 18k | 59.39 |
| 2017-09-30 | $1.1M | 19k | 57.75 |
| 2017-06-30 | $1.2M | 21k | 59.08 |
| 2017-03-31 | $811k | 15k | 55.13 |
| 2016-12-31 | $1.2M | 23k | 52.51 |
| 2016-09-30 | $2.9M | 50k | 57.45 |
| 2016-06-30 | $471k | 8.0k | 58.55 |
Top funds holding Vaneck Vectors Pharmaceutical etf
View all funds holding Vaneck Vectors Pharmaceutical etf